UPDATE: Spectrum Pharma shares slide 47% premarket after trial of lung cancer treatment misses main goal - MarketWatch Get link Facebook X Pinterest Email Other Apps - December 28, 2019 UPDATE: Spectrum Pharma shares slide 47% premarket after trial of lung cancer treatment misses main goal MarketWatch Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment